White Paper: Cannabis GMP.

ECI's white paper on the transition from cannabis licensing to pharmaceutical-grade operations. Covers the maturity journey, common gaps, key frameworks and the role of education and certification in supporting industry advancement.

1 min read · Last reviewed: July 2026 · European Cannabis Institute Editorial Team

This page is in preparation. Content will be published here as it becomes available. In the meantime, the resource below is the recommended next step.

References

  • EU GMP Part I and Part II
  • EMA Guideline on Good Agricultural and Collection Practice (GACP) for Starting Materials of Herbal Origin
  • ICH Q10 — Pharmaceutical Quality System

Confirm the current effective version and national applicability before operational, regulatory or clinical use.

Related reading

Article
EU GMP Annex 1 (2022) — Complete Guide
Article
What is EU GMP for Medical Cannabis?
Article
ICH Q9(R1) Quality Risk Management Explained
Article
EU GMP Annex 1 (2022) Explained for Cannabis Manufacturers
Article
ECI Commentary: EMA Cannabis Flos Quality Monograph